Maine INBRE is supported by a grant from the National Institute of General Medical Sciences (NIGMS) at the National Institutes of Health (NIH) to the MDI Biological Laboratory, with James Coffman, Ph.D., as the Program Director. The grant supports biomedical research by faculty and students at participating institutions through various means, including compensation, fellowships, salaries, research equipment, research supplies, travel to scientific meetings, renovation of laboratory space, and tuition. The grant also provides access to research equipment, software, and related services through Core facilities around the state.
Acknowledging INBRE and NIGMS Support
As a condition for accepting research support, either directly through a research award from the Maine INBRE Program or through the use of its Core Facilities or services, the beneficiaries are required to acknowledge the Maine INBRE grant in their scientific meeting abstracts, presentations and publications along with a disclaimer. This includes work done by INBRE-funded students.
To acknowledge NIH support, this language is suggested:
Research reported in this project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103423.
It may also be appropriate to include:
Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
The IDeA program builds research capacities in states that historically have had low levels of NIH funding by supporting basic, clinical and translational research; faculty development; and infrastructure improvements.
Core Facility users, as well as users of network institution’s facilities or equipment that were funded by Maine INBRE, are required to acknowledge the grant in a similar manner, even if their research is directly funded by other mechanisms.
Complying with NIH Public Access Policy
Submission to PubMed Central (PMC): The NIH requires that all scientists comply with the NIH Public Access Policy. This policy ensures that the public has access to the published results of NIH-funded research. It requires scientists to submit to the NIH repository PubMed Central, upon acceptance for publication, an electronic version of the final peer-reviewed manuscript resulting from research supported, in whole or in part, with direct costs from NIH. A valid PMCID# reflects successful submission to PubMed Central.
Since 2008, the NIH Public Access Policy has required that all peer-review journal publications that have been supported by an NIH award be shared within PubMed Central. At a minimum, the author must ensure that the “Author Accepted Manuscript” version of the paper is deposited into PubMed Central so to demonstrate compliance with this policy.
Recent Updates/Clarification to NIH Publication Policies
Prior to July 1, 2025, publications/authors were allowed to impose a 12 month embargo on any of their NIH Public Access deposit requirements.
After July 1, 2025 – No Embargo Allowed: authors depositing “Author Accepted Manuscript(s)” must do so without an embargo period. All NIH supported publications (either “author accepted manuscript” or “published version of record”) must be deposited into PubMed Central immediately upon the official date of publication. These papers must be made available freely within PubMed Central immediately (no embargo is permitted).
As of February 13, 2026 – Pre-Approval Required for foreign co-authors: The NIH is now enforcing a policy in place since 2003 that requires prior approval from NIH for any publications resulting from INBRE support that include investigators from foreign institutions as co-authors. If your INBRE-supported publication will include co-authors from a foreign institution, you must notify the Maine INBRE Program Director prior to publication to ensure the submission complies with conditions of the award. If warranted, a request may be submitted by the Program Director to the NIH for prior approval.
Submitting Journal Articles to PubMed Central
Depositing the author manuscript into PubMed Central does not require payment to the publisher for this specific action. After July 1st 2025, all such publications that are supported (in whole or in part) by NIH awards with be subject to the “Government Use License” (also known as the “Federal Purpose License”). This license provides the necessary permissions for authors (of the NIH supported publication) and the NIH to legally share the “Author Accepted Manuscript” freely within PubMed Central.
Compliance with the NIH Public Access Policy does not require additional funds to pay for open access fees. However, if an author chooses to publish with a journal/publisher that conditions article publication on the payment of a fee, that choice is at the sole discretion of the author(s). Note that a number of limitations exist before one might apply publication costs (APCs) directly to an NIH award.
Information about the PMCID submission process for journals.
The NIH Public Access Policy website provides instructions and tools to assist in submitting publications to PubMed Central and complying with the policy.
See NIH’s Supplemental Guidance on Publication Costs and the Government Use License and Rights.
Acknowledging Equipment/Services
Each institution that has INBRE-funded equipment or Core services should develop a plan for placing signage on/near the equipment to assist in educating those that use the equipment about the citing requirements and the need to submit related papers to PubMed Central.
Compliance
Failure to comply with the above requirements may result in delay of financial support by NIH until qualifying publications are in compliance.